AHG - Company ID 0001702318
The table below shows Akso Health Group's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $14.78M | $2.41M | $13.18M | $6.00M | $1.75M | $6.91M |
| Cost of revenue | $15.06M | $2.29M | $11.91M | $5.39M | $544.57K | $1.03M |
| Gross profit | -$281.53K | $122.13K | $1.27M | $605.13K | $1.75M | $6.91M |
| R&D | - | - | - | $421.19K | $441.40K | $117.94K |
Akso Health Group reported annual revenue of $14.78M for fiscal year 2025. That is up 512.1% from $2.41M in fiscal 2024. Over the 9 fiscal years shown, annual revenue declined from $22.92M (FY 2017) to $14.78M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $3.64M |
| $8.59M |
| $15.53M |
| $2.67M |
| $2.03M |
| $20.49M |
| Operating income | -$166.30M | -$8.64M | -$14.27M | -$3.26M | -$4.24M | -$48.11M |
| Income tax | -$30.80M | $24.99K | $17.55K | $92.82K | $482.98K | $489.95K |
| Net income | -$134.98M | -$9.46M | -$1.36M | -$16.85M | -$34.83M | -$71.20M |
| EPS (diluted) | -$0.16 | -$0.07 | -$0.02 | -$0.28 | -$0.71 | -$1.46 |